Interestingly, serum KL-6 levels were increased in COVID-19 patients (n = 83) compared to healthy subjects (n = 70), positively correlating with severity, but not when compared with serum levels in patients with other lung interstitial diseases (n = 31) including IPF and sarcoidosis [134]. Here, MUC1 is linked to COVID-19.